Dark Light

Postmenopausal Osteoporosis Medications

Postmenopausal osteoporosis is a condition characterized by weakened bones due to hormonal changes after menopause, leading to an increased risk of fractures. Medications are often prescribed to help strengthen bones, reduce the risk of fractures, and improve overall bone health in postmenopausal women.

 

Generic Names of Medications for Postmenopausal Osteoporosis

Common medications include bisphosphonates such as alendronate, risedronate, and ibandronate, as well as hormone replacement therapy options like estrogen and selective estrogen receptor modulators (SERMs) such as raloxifene. Additionally, denosumab is another effective medication used in treatment.

Showing the single result